Our maintenance manager Mr. Eino Moilanen has recently retired after a long and successful career of almost 20 years at Pharmatory. We all wish Eino active and enjoyable days with the new opportunities now available.
Eino’s duties at Pharmatory are succeeded by Mr. Antti Perkkiö. Antti has previously worked with various tasks in the security, IT management and process control sectors. The whole Pharmatory team looks forward to developing the company further with Antti as a member of the team.
The CPhI trade exhibition 2018 was held last month in Madrid, Spain. We would like to thank again all our current and new partners and customers for the fruitful meetings and look forward to fulfilling the aims agreed together. See you again next year in Frankfurt at the latest!
Pharmatory has again been ranked as a company with lowest credit risk classification by Dun & Bradstreet.
Fermion and Pharmatory have recently signed formal collaboration agreement to provide CDMO services for customers’ API development projects from preclinical to commercial stages. Our complementary service packages enable a seamless project transfer from early development and small scale manufacturing to further optimization and scale-up together with commercial production. Fermion is a fully owned subsidiary of Orion Corporation located in Finland, Europe.
Pharmatory and Orion Corporation have worked together for over 10 years in various API development projects. This proven collaboration, supported by our shared work ethics, standard practices and cultural coherence, ensures a safe and smooth transfer of all project-related information between the companies. The customer benefits from this collaboration as an unbroken path for API development and manufacturing for full product lifecycle and smaller investments in project outsourcing.
Please contact us for further details about our collaboration.
Mr. Niko Saari joined the Pharmatory team of chemistry experts in October 2017. Niko graduated from the University of Oulu in 2016 and his M.Sc. thesis in synthetic organic chemistry was titled ‘Mono- and regioselectivity in Suzuki-Miyaura cross-coupling reactions.’ He is eager to put his skills and enthusiasm into practise to help our customers achieve their goals.
Pharmatory participated BioPharm America in Boston 26.-27.9.2017. We thorougly enjoyed both the partnering meetings and the many informal discussions during the breaks and socializing time. Many thanks again to everyone involved and let’s keep on building further on the foundation laid in Boston!
Pharmatory has been ranked as a company with lowest credit risk classification by Dun & Bradstreet.
Dr. Sari Paavola joined Pharmatory today to strengthen our QA/QC team. Sari worked with us earlier for 7 years as R&D chemist and will now assume a new role as a QC chemist reporting to our QA director. We are all excited to welcome Sari back as a liked member of Pharmatory staff.
